Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases.
Dopamine (DA) and other receptors physically interact in the plasma membrane of basal ganglia neurons forming receptor mosaics (RMs). Two types of RMs are discussed, homomers formed only by DA-receptor (DA-R) subtypes and heteromers formed by DA-R associated with other receptors, such as A2A, A1, mGluR5, N-methyl-D-aspartate (NMDA), gamma-aminobutryic acid (GABA)-A, and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid. By being part of horizontal molecular networks, RMs tune multiple effector systems already at membrane level, such as G protein regulated inward rectifying potassium channels and dopamine transporter activity. Also, ligand-gated ion channels such as GABA-A and NMDA receptors are modulated by DA-R, e.g., in the striatal GABA output neurons through the formation of heteromeric complexes with these receptors. Thus, intramembrane DA-R-receptor interactions play an important role in the information handling in the basal ganglia. On this basis, functional implications of DA RM in physiological and pathological conditions are discussed. The effects of temperature on RM are discussed not only because receptor-decoding mechanisms are temperature sensitive, but also in view of the suggestion that possible ordering effects (i.e., changes in the entropy of a receptor complex) induced by a ligand are as a result of alterations in the receptor oligomerization (i.e., are related to rearrangements of the RM). Hence, brain temperature may have profound effects on brain integrative functions not only because its effects on the kinetics of biochemical reactions, but also for its effects on receptor geometry, building up of RM, and alterations in protein expression, as is the case of H-channels following febrile seizures.
Agnati
Luigi Francesco
LF
Department of BioMedical Sciences, University of Modena and Reggio Emilia, via Campi 287, 41100 Modena, Italy. luigiagnati@tin.it
Ferre
Sergi
S
Burioni
Raffaella
R
Woods
Amina
A
Genedani
Susanna
S
Franco
Rafael
R
Fuxe
Kjell
K
D000818:Animals; D001479:Basal Ganglia / Q000378:metabolism* / Q000503:physiopathology; D001480:Basal Ganglia Diseases / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D002462:Cell Membrane / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D007473:Ion Channels / Q000737:chemistry / Q000378:metabolism; D046911:Macromolecular Substances / Q000737:chemistry / Q000378:metabolism; D009474:Neurons / Q000378:metabolism*; D020239:Receptor Cross-Talk / Q000502:physiology; D011954:Receptors, Dopamine / Q000737:chemistry / Q000378:metabolism*; D017470:Receptors, Glutamate / Q000737:chemistry / Q000378:metabolism
D007473:Ion Channels; D046911:Macromolecular Substances; D011954:Receptors, Dopamine; D017470:Receptors, Glutamate